Theralase Technologies Inc
XTSX:TLT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Theralase Technologies Inc
XTSX:TLT
|
CA |
Intrinsic Value
The intrinsic value of Theralase Technologies Inc (TLT) under the Base Case is 0.17 CAD per share.
Compared with the current market price of 0.2 CAD, the stock appears
Overvalued by 17% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Theralase Technologies Does
Theralase Technologies makes medical laser systems used by doctors and clinics to treat pain, inflammation, and certain soft-tissue conditions without drugs or surgery. It designs and sells these devices, along with related treatment protocols and support, to healthcare providers that want to use light-based therapy in their practice.
- Headquarters
- Canada CA
- Employees
- 20
- IPO date
- Nov 2, 2004
Revenue & Expenses Breakdown
Theralase Technologies Inc
Earnings Waterfall
Theralase Technologies Inc
The intrinsic value for Theralase Technologies Inc (TLT) under the Base Case is 0.17 CAD.
Compared with the current market price of 0.2 CAD, the stock appears Overvalued by 17% .